- A
bispecific monoclonal antibody (BsMAb, BsAb) is an
artificial protein that can
simultaneously bind to two
different types of
antigen or two different...
- Bi-specific T-cell
engagers (BiTEs) are a
class of
artificial bispecific monoclonal antibodies that are
investigated for use as anti-cancer drugs. They...
- Emicizumab, sold
under the
brand name Hemlibra, is a
humanized bispecific monoclonal antibody for the
treatment of
haemophilia A,
developed by Genentech...
-
brand name Columvi, is a
bispecific monoclonal antibody used for the
treatment of
large B-cell lymphoma. It is a
bispecific CD20-directed CD3 T-cell engager...
- Tecvayli, is a
human bispecific monoclonal antibody used for the
treatment of
relapsed and
refractory multiple myeloma. It is a
bispecific antibody that targets...
-
investigational drug
being evaluated for use in
cancer immunotherapy. It is a
bispecific antibody targeting PD-L1 and CTLA-4. "Erfonrilimab - Alphamab". AdisInsight...
-
Odronextamab (REGN1979) is a CD20 x CD3
bispecific monoclonal antibody that is
developed by
Regeneron Pharmaceuticals for B-cell non-Hodgkin lymphoma....
-
various cancer types when co-administered with
bispecific SMDC
adaptor molecules.
These unique bispecific adaptors are
constructed with a FITC molecule...
- antigens, in
which case they are
types of
bispecific antibodies. The
furthest developed of
these are
bispecific tandem di-scFvs,
known as bi-specific T-cell...
- 27001, 27017 in 2022. Also in 2022,
Samsung Biologics launched S-DUAL, a
bispecific antibody platform, and its
DEVELOPICK platform, a
service that selects...
